Compare Ecolab Inc. (ECL) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ecolab Inc. vs Tempus AI — how do they compare? Ecolab Inc. trades at $281.83 (market cap $78.97B), while Tempus AI trades at $70.93 (market cap $12.58B). The key difference: Ecolab Inc. is far larger — about 6.3× Tempus AI's market cap, and Ecolab Inc. pays a 1.04% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ecolab Inc. for 90 Days and Tempus AI for 23 Days on average.
| ECL | TEM | |
|---|---|---|
Market Cap | $78.97B | $12.58B |
Volume | 974,947 | 7,444,569 |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $308.35 | $99.28 |
52-Week Low | $245.73 | $41.55 |
Typical Hold Time | 90 Days | 23 Days |
Enterprise Value | $87.75B | $13.21B |
Dividend Yield | 1.04% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ECL trades at $281.69, up 1.29% with strong analyst support (78% buy ratings) and a $326.38 consensus target. The stock shows bullish technical momentum above key support at $279, supported by improving fundamentals including 9.7% Q2 sales growth and consistent dividend increases. Recent institutional buying and director purchases signal confidence ahead of Q3 earnings on October 27.
Outlook remains positive with High-Tech and Digital segments driving growth, though elevated P/E of 37.8 and rising debt from the CoolIT acquisition present valuation and execution risks. The dividend aristocrat status and essential service model provide stability, making ECL attractive for long-term investors despite near-term cost pressures.
Tempus AI (TEM) trades at $70.93, up 0.91% today, with a bullish technical signal and strong analyst support. The stock shows robust revenue growth, with 2026 revenue reaching $1.4B, but remains unprofitable with a net margin of -17.77%. Recent FDA clearance for its ECG-MR AI product and positive ESMO Congress abstracts highlight innovation momentum, though negative cash flow from operations and insider selling pose concerns.
Outlook is cautiously optimistic given 64% buy ratings and a $72.60 consensus target, but profitability challenges and high valuation multiples (P/S 8.61, P/B 28.27) demand scrutiny. Key risks include sustained losses, competitive pressures, and reliance on financing activities for liquidity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Ecolab Inc.
Ecolab produces and markets cleaning and sanitation products for the hospitality, healthcare, and industrial markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. The company has a strong hold on the U.S. market and is looking to increase its profitability abroad. Additionally, Ecolab serves customers in water, manufacturing, and life sciences end markets, selling customized solutions.
Read more on ECL →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
